Allergon

Quick links to important sections

Allergon

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Allergon

Property Description
Active ingredient Chlorphenamine maleate
Form Tablet, oral solution, parenteral formulation
Pharmacological class Antihistamine (H₁-receptor antagonist)
Type First-generation
Origin Synthetic compound

The Identity and Classification of Allergon

Allergon is a medicinal preparation whose active constituent is Chlorphenamine maleate (INN), a well-recognized therapeutic agent utilized to mitigate symptoms resulting from hypersensitivity reactions. It is fundamentally categorized as an antihistamine belonging to the alkylamine chemical class. Chlorphenamine is classified as a first-generation antihistamine, reflecting its historical use and established pharmacological profile as an H₁-receptor antagonist.

Composition, Origin, and Available Forms

The therapeutic effect of Allergon is derived exclusively from the single active component, Chlorphenamine maleate, which is a purely synthetic compound manufactured through chemical processes. This compound is administered for systemic effect, primarily available in the solid tablet form for oral use, and is also supplied as an oral solution and a parenteral formulation for specialized administration. The availability of the oral solution particularly addresses the needs of patient groups, such as children, who may require a liquid format.

General Purpose of This Antihistamine Type

The core function of Allergon is to offer systemic relief by interrupting the physiological hyperactivity associated with various allergic conditions, such as seasonal rhinitis. It achieves this by functioning as an H₁-receptor antagonist, executing a histamine blockade that prevents the body's released histamine from triggering subsequent cellular responses. Chlorphenamine is a clinically well-established compound for the symptomatic relief of allergic responses. This profile supports the drug's reliable therapeutic role in counteracting the fundamental effects of histamine release across various body systems.

What side effects are possible with Allergon?

Possible side effects and safety information

The safety profile of Allergon (Chlorphenamine maleate) is characterized by the established effects of a first-generation antihistamine, with documented adverse reactions classified by frequency and System-Organ Class (SOC) in regulatory documents.

Adverse Reactions by Frequency

The most frequent adverse reactions involve the central nervous system (CNS):

Frequency Classification Examples of Adverse Reactions (Label-Documented)
Very Common (ge 1/10) Sedation, Somnolence (Drowsiness)
Common (ge 1/100 to < 1/10) Dizziness, Headache, Disturbance in attention, Nausea, Dry mouth, Fatigue
Not Known Blood dyscrasias, Anaphylaxis, Seizures, Confusion, Hepatic effects

Systemic and Serious Safety Patterns

The official adverse reaction listing includes effects across multiple SOCs. Nervous System Disorders and Psychiatric Disorders cover the range from somnolence to rare paradoxical excitation, which is noted to be more likely in older adults and children. Gastrointestinal Disorders include dry mouth and constipation, which reflect the drug’s anticholinergic properties.

Officially documented Serious Adverse Reactions include severe events such as Anaphylactic Reactions, certain Blood Dyscrasias (e.g., haemolytic anaemia, agranulocytosis), and Arrhythmias, which are typically classified in the Not Known frequency category.

Population-Specific Safety Considerations

Regulatory documents advise caution for specific patient groups. Older adults have an increased risk of experiencing neurological effects such as confusion and somnolence. Caution is also explicitly advised in patients with existing hepatic or renal impairment. Furthermore, the label notes that use during the third trimester of pregnancy may carry a risk of reactions in the newborn.

Overdose and Emergency Response

The official regulatory documentation for Allergon (Chlorphenamine maleate) outlines specific clinical manifestations and mandated emergency actions in the event of an overdose.

Documented signs of overdose primarily involve severe effects on the Central Nervous System (CNS), which can present dually as extreme depression—leading to profound sedation or coma—or as paradoxical stimulation, marked by excitement, hallucinations, unsteadiness, and potentially seizures or hyperpyrexia (severe fever). Accompanying these are signs of an anticholinergic syndrome, including dilated pupils, flushing, and urinary retention.

Overdose is officially classified as potentially severe or life-threatening due to the risk of serious complications. These documented outcomes include cardiovascular collapse, severe hypotension, dangerous cardiac arrhythmias, and respiratory depression. Regulatory bodies mandate that immediate medical attention must be sought for any suspected overdose. Contacting emergency services or a poison control center immediately is required.

Official regulatory guidance states that no specific antidote is known for Chlorphenamine maleate toxicity. Management focuses entirely on symptomatic and supportive treatment, which may include procedures like gastric decontamination and continuous monitoring. Regulatory labeling also specifies that children are particularly vulnerable to CNS excitation and seizures, while the elderly are susceptible to more severe anticholinergic effects and hypotension.

Therapeutic Uses of Allergon

Main Uses and Benefits

Allergon (chlorphenamine maleate) is used to provide symptomatic relief for conditions characterized by periods of heightened symptoms affecting the nose and eyes, such as seasonal hay fever or perennial allergies. This medication helps address symptoms of sneezing, persistent runny nose, nasal itching, and the discomfort of red, watery, and itchy eyes, helping to ease the overall symptom burden.

The therapeutic scope includes relief for conditions such as allergic rhinitis, acute dermal allergic reactions, urticaria (hives), and managing symptom clusters that may accompany the common cold. It is used when short-term symptomatic assistance is needed to help ease the intensity of itching and associated swelling.

The medication helps ease the overall symptom burden, supporting patients during episodes of heightened discomfort.

This focus on managing challenging symptoms assists with maintaining functional stability when symptoms become more noticeable, contributing to day-to-day comfort during symptomatic periods. Allergon is used in clinical settings where symptoms are part of acute episodes, such as during a sudden allergic flare-up or when symptoms interfere with routine activities.

Support for Pruritic Symptoms
Allergon may assist with managing intense itching and associated visible swelling linked to hives or insect bites, supporting skin comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Allergon — Official Regulatory Information

Eligibility Scope

  • Populations for whom use is allowed (as stated in label): Adults and adolescents aged 12 years and older. Use is also permitted in children aged 6 to 12 years at a regulatory-defined dosage.
  • Populations for whom use is contraindicated: Patients with a documented hypersensitivity to chlorphenamine maleate or its excipients, or those currently taking or having discontinued a Monoamine Oxidase Inhibitor (MAOI) within 14 days. Absolute prohibition also applies to neonates and premature infants.
  • Condition-specific eligibility rules: Official labels list conditions requiring caution or avoidance, including narrow-angle glaucoma, prostatic hypertrophy, urinary retention, severe hypertension, and severe coronary artery disease. Caution is also advised for patients with mathbfhepatic or mathbfrenal impairment.
  • Age-related eligibility rules: The medicine is mathbfnot recommended for children under 6 years. Use in the elderly is generally mathbfavoided due to increased susceptibility to neurological anticholinergic effects.
  • Pregnancy and lactation eligibility status: Use is mathbfnot recommended during pregnancy or lactation unless considered mathbfessential by a health professional.

Eligibility Classifications (High-Level)

  • Eligibility severity classification: Regulatory status includes mathbfContraindicated, mathbfNot Recommended, and mathbfCaution (conditional use).
  • Eligibility-context constraints: Constraints are often based on anticholinergic susceptibility, impacting use in the elderly and those with conditions like mathbfglaucoma or mathbfprostatic hypertrophy.

Resulting eligibility structure

Official eligibility statements explicitly prohibit use in specific clinical contexts and require special consideration for those with pre-existing organ or chronic disorders before use is permitted.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation requires caution or avoidance when Allergon is used alongside certain medicinal products and substances, primarily due to an increased risk of additive side effects or altered drug levels. These interactions are officially classified by severity, ranging from Major (Avoid Combination) to Moderate (Usually Avoid Combination, use under special circumstances).

Interacting Medicinal Product Categories

Interaction Type Examples of Interacting Categories/Agents
Central Nervous System (CNS) Depressants Alcohol, sedatives, tranquilizers, certain opioid pain medicines, and other antihistamines.
QTc Prolonging Agents Specific antiarrhythmics, antipsychotics, certain antidepressants, and some antibiotics.
Anticholinergic Agents Certain tricyclic antidepressants, antipsychotics, and other medicines with anticholinergic properties.
Enzyme Modulators Inhibitors or inducers of certain metabolic enzymes, which can increase or decrease Allergon blood levels.

Key Regulatory Requirements

Co-administration with CNS depressants, including alcohol, may result in profound additive effects and is advised against in official labeling unless under medical consultation. Concomitant use with agents that also prolong the QT interval is contraindicated due to the heightened risk of serious cardiac arrhythmias. The product’s interaction profile also notes that individuals with pre-existing conditions such as heart disease, glaucoma, or severe hepatic/renal impairment require specific medical guidance to manage interaction constraints.

Mechanism of Action

Allergon (Chlorphenamine maleate) modulates physiological systems through a combination of on-target and inherent off-target mechanisms, focusing on pathways associated with elevated signal transduction. The drug's primary mechanism involves acting as an inverse agonist at the Histamine H1-receptor (peripheral and central). This molecular interaction stabilizes the receptor in an inactive conformation, suppressing the signal transduction normally initiated by endogenous histamine. This cascade modifies early molecular steps, leading to a reduction in histamine-induced capillary permeability and the modulation of sensory nerve ending stimulation.

Due to its lipophilicity, the molecule penetrates the blood-brain barrier, modulating CNS histaminergic neurotransmission and altering CNS arousal. Concurrently, it engages in competitive antagonism at muscarinic cholinergic receptors in peripheral systems, contributing to a decrease of glandular output. The overall mechanism is strictly confined to these molecular targets, meaning its action is mechanistically constrained in inflammatory states dominated by non-histamine mediators (e.g., leukotrienes).

Dosage and Administration Information

Allergon (Chlorphenamine maleate) is administered via both the oral route and the parenteral route, depending on the formulation and clinical need. Oral administration involves immediate-release tablets, extended-release forms, or oral solutions. The parenteral form is a solution used for Intramuscular, Subcutaneous, or slow Intravenous injection.

For the immediate-release oral form, the standard adult dose is 4 mg taken every 4 to 6 hours as required. A minimum interval of four hours must be observed between doses, and the total daily intake must not exceed 24 mg in any 24-hour period. The medication may be taken with or without food. Extended-release forms are typically dosed every 8 to 12 hours for prolonged systemic delivery.

Administration rules vary by population. For pediatric patients aged 6 to 12 years, the standard dose is reduced to 2 mg every 4 to 6 hours, with a lower daily maximum limit. Dosing adjustments are also applicable for older adults, for whom a lower maximum daily intake, such as 12 mg, is advised. When the parenteral solution is administered intravenously, it must be infused slowly over one minute. The drug is intended for short-term use and continuous administration should not generally exceed two weeks without professional review.

Recent Clinical Evidence

Research Evidence for Allergon

This section provides an overview of the types of research and studies that have been conducted to evaluate Allergon (Chlorphenamine maleate), focusing on the structure of the evidence and what remains uncertain, based on official regulatory and scientific reviews.


Evidence for Use in Seasonal and Perennial Allergic Rhinitis

Research exploring the use of Allergon in conditions characterized by fluctuating or episodic manifestations, such as seasonal or perennial allergic rhinitis, has relied primarily on short-term, randomized controlled trials (RCTs). These studies were used in research exploring how symptoms change over time, comparing the drug to an inactive substance (placebo) and sometimes to other active agents. The main outcomes monitored in these trials were patient-reported outcomes describing perceived discomfort, such as specific symptom scores. Research examined how symptoms evolved in the observed populations, with a focus on metrics related to nasal symptoms like sneezing, runny nose, and itching, as well as associated allergic eye discomfort. These studies contribute to understanding symptom patterns by describing how outcomes related to physical discomfort evolved in the observed populations during the short-term treatment period. While evidence contributes to understanding symptom patterns, long-term effects are not fully established. Follow-up durations were limited, meaning there is limited information for long-term outcomes or how the study of outcomes related to systemic or functional imbalance changes over extended time intervals. Also, the findings describe group patterns, not personal outcomes, and results apply only to the populations studied.

Evidence for Use in Acute Dermal Allergic Reactions

Allergon was evaluated in research contexts involving fluctuating or unstable symptoms such as acute episodes of hives (urticaria) or generalized allergic itching. The evidence for this indication is often drawn from older, established clinical studies and subsequent systematic reviews that analyzed the findings across similar medications. The studies explored outcomes related to physical discomfort, particularly the measurement of patient-reported pruritus scores (itching intensity) and visible reactions, such as changes in the size of wheals or swelling. These findings describe patterns observed in the studies related to the acute, temporary nature of these reactions. The research base for this indication is considered to have high diversity across studies, especially for long-term use in chronic conditions like persistent itching or chronic hives. Data for certain groups remain insufficient, and evidence quality varies across studies when examining use beyond immediate, acute episodes.

What is Still Uncertain About Allergon (Research Gaps)

The available research provides context but not individual predictions, and evidence highlights what is known—and what is still uncertain.

Key research gaps include:

  • Long-term outcomes: There is limited information for long-term outcomes, and research exploring durability of response beyond the short-term trial period is not well characterized.
  • Comparative evidence: Data for certain groups remain insufficient, such as rigorous, recent comparative studies against newer-generation antihistamines or specific studies focusing on certain specialized patient groups.
  • Monotherapy data: The evidence base for common cold relief is often derived from combination products, and specific data for Allergon as a single ingredient in this context are still emerging.

Key Studies & References

  1. Chlorpheniramine - NIH MedlinePlus Drug Information
  2. First generation antihistamines for allergic rhinitis: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Allergon (FAQ)


Q: How quickly does Allergon usually start working?

Official medical references indicate that Allergon typically begins to take effect relatively quickly. After taking the medicine by mouth, the onset of effect is often described as occurring within 30 to 60 minutes.

Q: Are there any common foods that should be avoided when taking Allergon?

The official regulatory labeling for Allergon does not specify any common foods that must be strictly avoided. According to this information, the medicine may be taken with or without food.

Q: What happens if I miss a dose of Allergon?

The general information suggests that a dose may be taken when remembered. However, regulatory guidance describes skipping the missed dose if it is close to the time for the next scheduled dose. Official product information advises against taking a double dose.

Q: Is Allergon available over-the-counter?

Allergon, in its lower strength tablet form (typically 4 mg), is often legally classified as an Over-the-Counter (OTC) medicine in certain jurisdictions. This OTC status allows it to be purchased without a prescription.

Q: Why is a prescription needed for Allergon?

Prescription (Rx) status is generally required for Allergon when it is manufactured in higher strength formulations. It is also required for the injectable forms, which are reserved for specialized administration due to greater associated risks.

Q: Does Allergon cause weight gain?

Official regulatory adverse reaction tables do not list weight gain as one of the commonly or officially documented side effects of single-ingredient Allergon.

Q: What should I do if a side effect seems serious?

Official documents list certain events, such as anaphylaxis or blood dyscrasia, as potential serious adverse reactions. Prompt medical attention is advised if such signs occur.

Q: Does Allergon contain any common allergens like gluten or lactose?

Some oral tablet formulations of Allergon contain inactive ingredients (excipients) such as lactose and corn starch. Because excipient lists can vary by manufacturer and product form, it is necessary to check the official product labeling for the specific product being used.

Q: What is the proper way to stop taking Allergon?

The medicine is intended for temporary symptom relief, and official documents generally do not contain specific instructions for tapering the dose. The medicine can usually be stopped when the allergic symptoms have subsided.

Q: Do health regulators classify Allergon as a controlled substance?

As a single-ingredient product, Allergon is not classified as a federally controlled substance by health regulators in the United States.

Q: Is there evidence for Allergon's use in food allergies?

The drug is officially indicated for the relief of symptoms associated with seasonal allergies and acute hives. Official documentation does not indicate or recommend Allergon for the treatment or prevention of food allergies or life-threatening allergic emergencies.

Q: What are the official recommendations regarding sun exposure while on Allergon?

Some regulatory documents advise that certain antihistamines can potentially increase skin sensitivity to sunlight, a condition known as photosensitivity. Although this is not a common side effect for Allergon, protective measures such as wearing appropriate clothing or using sunscreen may be considered.

Q: Can Allergon be taken alongside herbal supplements?

Regulatory warnings generally advise a cautious approach with herbal supplements. Supplements that cause drowsiness or have anticholinergic effects may add to the side effects already associated with Allergon.

Q: How long does it take for Allergon to clear out of the body?

Information from official sources regarding pharmacokinetics describes the elimination half-life of the drug. The time required for the body to reduce the drug's concentration by half is reported to be within the range of 13.9 to 43.4 hours.

Q: Are there any known issues with taking Allergon before or after surgery?

Due to potential for additive effects with other medicines, regulatory information suggests ensuring a healthcare provider is aware if the drug is being taken prior to or following a surgical procedure. This is especially important if other sedating medicines are involved.

Q: Do studies support using Allergon for allergic asthma?

Allergon is utilized for symptoms of upper respiratory allergies, such as allergic rhinitis. However, official product information indicates the drug is not specifically indicated or recommended for the treatment of asthma itself.

Q: Does Allergon have a Black Box Warning from the FDA?

The active ingredient, Chlorphenamine maleate, as a single-ingredient product, does not carry a Black Box Warning (BBW) from the FDA. This is the highest level of regulatory warning for prescription medicines.

Q: What are the reported effects of Allergon on blood sugar levels?

When reviewing the most common adverse reactions for single-ingredient Allergon, there are no reported effects on blood sugar (glucose) levels listed in official documents.

Q: Does taking Allergon long-term cause any problems?

Official documents advise that the use of Allergon should not generally exceed two weeks without professional review. Furthermore, studies indicate that long-term safety data are limited, as research trials typically focus on short-term outcomes.

Q: What is the main difference between Allergon and other allergy pills?

Allergon is classified as a first-generation antihistamine. This pharmacological class is characterized by having highly sedating effects and also exhibiting anticholinergic properties, unlike the newer second-generation alternatives.

Q: Do studies show Allergon works for chronic hives?

Evidence supports the use of Allergon for acute allergic reactions and short-term rhinitis. However, studies and official documentation indicate that data on the long-term efficacy for chronic hives (urticaria) are limited.

Q: Are there any warnings about driving or operating machinery while taking Allergon?

Regulatory labels contain specific information concerning activities such as driving or operating heavy machinery. Due to the high risk of experiencing drowsiness or dizziness (sedation), caution is generally advised.

Q: Can Allergon be taken with common pain relievers like ibuprofen?

Official information indicates that co-administration with common non-opioid pain relievers, such as ibuprofen or paracetamol, is generally permitted. Caution is advised when combining it with opioid pain medicines due to the potential for increased drowsiness.

Q: How does Allergon affect the immune system?

The primary function of Allergon is molecular: it works by binding to the H1-receptor to block the effects of histamine. This action helps modulate the symptoms of an allergic response but is not considered to broadly suppress the entire immune system.

Q: What is the difference between the adult and pediatric formulations of Allergon?

The oral solution is typically used for pediatric patients and often differs from adult tablets in terms of inactive ingredients (excipients) and flavoring. Official documents also confirm that the concentration (mg/mL) of the solution is different to allow for accurate dosing of children.

How should Allergon be stored and disposed of?

Storage Conditions for Allergon (Chlorphenamine Maleate)

Requirement Official Labeled Condition
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Store away from excessive heat.
Protection Protect tablets and oral solution from moisture. Protect the injection formulation from light.
Packaging The oral solution must be stored in a tightly closed container.
Safety The medication must always be kept out of the reach of children.

Disposal of Unused Product

Allergon must be discarded after the expiration date printed on the packaging. Unused or expired portions must be disposed of according to the specific consumer guidelines established by the national regulatory authority. To prevent environmental contamination, unused medicine should not be disposed of via wastewater unless regulatory instructions explicitly permit it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Allergon found in:

A-Z Index: